Yes. I think that when it comes to really understanding complex diseases, we really need to arm ourselves with objective data, which is often what is lacking in these types of circumstances for the diagnosis, and then eventually for the management of these patients.
Having a structure where we have several centres involved, where we could not only harmonize our data collection, but also pool it together or integrate it would be a lot more powerful at getting at meaningful tools like diagnostic biomarkers and potentially therapeutic targets that we could put into clinical trials.